AMGEN Inc [NASDAQ: AMGN] traded at a low on 2025-12-04, posting a -1.52 loss after which it closed the day’ session at $340.16.
The results of the trading session contributed to over 3695556 shares changing hands. Over the past one week, the price volatility of AMGEN Inc stands at 1.91% while the volatility over the past one month is 2.51%.
The market cap for AMGN stock reached $183.17 billion, with 538.50 million shares outstanding and 537.46 million shares in the current float. Compared to the average trading volume of 2.61M shares, AMGN reached a trading volume of 3695556 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about AMGEN Inc [AMGN]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AMGN shares is $330.79 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMGN stock is a recommendation set at 2.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Truist have made an estimate for AMGEN Inc shares, keeping their opinion on the stock as Hold, with their previous recommendation back on November 24, 2025. While these analysts kept the previous recommendation, Scotiabank raised their target price to Sector Outperform. The new note on the price target was released on November 13, 2025, representing the official price target for AMGEN Inc stock.
The Price to Book ratio for the last quarter was 19.04, with the Price to Cash per share for the same quarter was set at 17.54. Price to Free Cash Flow for AMGN in the course of the last twelve months was 15.87 with Quick ratio for the last quarter at 0.99.
How has AMGN stock performed recently?
AMGEN Inc [AMGN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.28. With this latest performance, AMGN shares gained by 14.65% in over the last four-week period, additionally plugging by 18.48% over the last 6 months – not to mention a rise of 30.51% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMGN stock in for the last two-week period is set at 60.59, with the RSI for the last a single of trading hit 7.41, and the three-weeks RSI is set at 7.41 for AMGEN Inc [AMGN]. The present Moving Average for the last 50 days of trading for this stock 310.82, while it was recorded at 341.38 for the last single week of trading, and 296.57 for the last 200 days.
AMGEN Inc [AMGN]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and AMGEN Inc [AMGN] shares currently have an operating margin of 28.56% and a Gross Margin at 70.47%. AMGEN Inc’s Net Margin is presently recorded at 19.52%.
AMGEN Inc (AMGN) Capital Structure & Debt Analysis
According to recent financial data for AMGEN Inc. ( AMGN), the Return on Equity (ROE) stands at 81.71%, highlighting impressive shareholder gains. The Return on Assets (ROA) is 7.74%, reflecting the company’s efficiency in generating profits from its assets. Additionally, AMGEN Inc’s Return on Invested Capital (ROIC) is 11.29%, showcasing its effectiveness in deploying capital for earnings.
AMGEN Inc (AMGN) Efficiency & Liquidity Metrics
Based on AMGEN Inc’s (AMGN) latest financial statements, the Debt-to-Equity Ratio is 5.67%, indicating its reliance on debt financing relative to shareholder equity.
AMGEN Inc (AMGN) Efficiency & Liquidity Metrics
From an operational efficiency perspective, AMGEN Inc. (AMGN) effectively leverages its workforce, generating an average of $250000.0 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.28% and a Quick Ratio of 0.99%, indicating strong ability to cover short-term liabilities.
Earnings analysis for AMGEN Inc [AMGN]
With the latest financial reports released by the company, AMGEN Inc posted 5.31/share EPS, while the average EPS was predicted by analysts to be reported at 5.08/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.23. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMGN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for AMGEN Inc go to 4.70%.
Insider trade positions for AMGEN Inc [AMGN]
There are presently around $83.83%, or 84.01%% of AMGN stock, in the hands of institutional investors. The top three institutional holders of AMGN stocks are: VANGUARD GROUP INC with ownership of 51.87 million shares, which is approximately 9.6598%. BLACKROCK INC., holding 46.04 million shares of the stock with an approximate value of $$14.39 billion in AMGN stocks shares; and BLACKROCK INC., currently with $$9.05 billion in AMGN stock with ownership which is approximately 5.3951%.
